Exhalation pattern changes during fasting and low dose glucose treatment in rats
Tobias Fink1, Frederic W Albrecht, Felix Maurer
1Department of Anaesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center, Kirrbergerstraße, 66421, Homburg, Saar, Germany, tobias.fink@uks.eu.
Analytical and Bioanalytical Chemistry
|March 27, 2015
Summary
Fasting and glucose administration significantly alter volatile organic compounds in exhaled breath. This finding is crucial for accurate long-term breath analysis in medical research and disease monitoring.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Metabolomics
Background:
- Breath analysis of volatile organic compounds (VOCs) is a promising non-invasive technique.
- Long-term monitoring of VOCs is vital for tracking disease progression and treatment efficacy.
- The impact of fasting and glucose on breath analysis requires thorough investigation.
Purpose of the Study:
- To investigate the effects of fasting and glucose infusion on exhaled volatile metabolites.
- To determine the influence of these factors on breath analysis for medical research.
Main Methods:
- Utilized a rat model with continuous intravenous infusion, comparing glucose and no-glucose groups over 12 hours.
- Analyzed exhaled gas using multicapillary column ion-mobility spectrometry (MCC/IMS).
- Identified analytes using the BS-MCC/IMS database.
Main Results:
- Glucose infusion significantly increased blood glucose and cardiac output.
- Ten volatile organic compounds showed significant concentration differences between groups.
- Compounds like isoprene, acetone, and various alcohols were notably affected by glucose administration.
Conclusions:
- Fasting and glucose administration demonstrably alter VOC profiles in exhaled air.
- These metabolic conditions must be carefully controlled for reliable long-term breath analysis.
- The study highlights the need to account for nutritional status in breath diagnostics.
Related Concept Videos
Metabolic States of the Body: Fasting and Starvation
3.4K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
3.4K
Metabolic States of the Body: The Postabsorptive State
1.6K
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
1.6K
Glucose Homeostasis: Regulation of Blood Glucose
5.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
5.5K
Hypoglycemia and Glucagon
1.4K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.4K
Hormones Regulating Blood Glucose
9.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
9.0K


